Intraocular (Uveal) Melanoma Treatment
Uveal melanoma is the most common primary intraocular malignancy in adults.
This PDQ cancer information summary for health professionals provides comprehensive, peer‑reviewed, evidence‑based information about the treatment of intraocular melanoma. It is intended as a resource to inform and assist clinicians in the care of their patients. It does not provide formal guidelines or recommendations for making health care decisions.
It is the most common primary intraocular malignancy in adults, and its management requires specialized knowledge due to poor survival after metastatic spread.
Bizonyítékszint: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Kapcsolódó jelek
- Beyond the Five-Year Milestone: Long‑term Survivorship of Melanoma Patients Treated Off‑Trial with anti‑PD‑1
- Uveal Melanoma – Trials in Disease – Overview of Information and Clinical Research
- A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
- Melanoma Research
- The Clinical Trial Landscape for Melanoma Therapies